Iain Stuart - 30 Sep 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Scientific Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Iain Stuart
Issuer symbol
VYNE
Transactions as of
30 Sep 2021
Net transactions value
-$2,057
Form type
4
Filing time
01 Oct 2021, 17:12:27 UTC
Previous filing
03 Sep 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $2,057 -1,480 -0.95% $1.39 155,129 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.